Leishmania spp. are obligate intracellular parasites of mammalian macrophages. Infection of mice with Leishmania major, one of the causes of human cutaneous leishmaniasis, results in clinical manifestations that mimic the spectrum of leishmaniases caused by different Leishmania species in humans. Mice from the majority of strains, such as CBA or C57BL/6, are resistant to infection in that they develop only small lesions that resolve spontaneously, leaving the animal immune to reinfection. In contrast, mice from a few strains, typified by BALB/c, are susceptible to infection and develop severe cutaneous lesions at the site of parasite inoculation, which is followed by visceralization of the infection and death (1, 10) . The extreme susceptibility of BALB/c mice to infection with L. major can be overcome by a variety of experimental manipulations (6, 14, 38) . For example, treatment of BALB/c mice with anti-CD4 monoclonal antibody (MAb) at the beginning of infection induces the expression of a resistant phenotype in these otherwise susceptible mice (21, 31, 39, 46) .
Although specific CD4+ T cells and the cytokines they produce make a significant contribution to the resolution of lesions induced by a primary infection with L. major (20, 22, 27, 41) , indirect evidence indicates that CD8+ T cells can also play a role in immunity to a primary infection with both L. major and Leishmania donovani. CD8+ T cells from L. major-infected resistant CBA mice were shown to transfer Leishmania-specific delayed-type hypersensitivity (DTH) reactions to syngeneic recipients, providing evidence for the triggering of parasite-specific CD8+ T cells during infection with L. major (26) . In contrast to normal immune resistant mice, which develop only small, rapidly healing secondary lesions, animals that receive anti-CD8 MAb at the time of reinfection develop severe, slowly healing secondary lesions (28) . The anti-CD8 MAb treatment also reverses the immunity to reinfection induced in BALB/c mice made resistant either by vaccination with killed L. major promastigotes or by intervention with anti-CD4 or with anti-interleukin 4 (IL-4) MAb (6, 30) . Taken together, these data provide indirect evidence that Leishmania-specific CD8+ T cells contribute to the efficient control of secondary infection in immune mice, suggesting that CD8+ T cells participate in the secondary immune response triggered by reinfection of immune mice.
Therefore, the purpose of this study was to assess directly the contribution of Leishmania-specific CD8+ T cells to the memory response triggered by the challenge of immune mice with L. major. It is indeed important to characterize carefully the cellular parameters of the memory response mounted by immune mice after reinfection since, ideally, vaccines should sensitize the host for the elicitation of protective memory responses upon infection. The observation that spleen and lymph node cells from reinfected, immune mice produce substantially more gamma interferon (IFN--y) in vitro in response to specific stimulation than immune cells obtained from unchallenged mice clearly indicates that a secondary response is triggered upon reinfection. The participation of CD8+ T cells in this secondary response elicited by reinfection was demonstrated by our findings that the CD8+ T cells present in the lymphoid tissues of immune reinfected mice mounted a much higher IFN-,y response upon specific stimulation in vitro than those from immune mice which had not been rechallenged. The production of IFN--y was used as a parameter for T-cell activation since IFN-y is essential for the efficient activation of parasitized macrophages, permitting them to kill intracellular L. major (35, 47) .
Finally, the contribution of IFN--y to the recall of immunological memory was also assessed by examining the effects of neutralization of this cytokine at the time of reinfection on the development of Leishmania-specific DTH.
Parasites. L. major LV 39 (MRHO/SU/59/P-strain) was maintained in virulent form by monthly passage in mice.
Parasites isolated from skin lesions of infected mice were grown at 26°C in Dulbecco's modified Eagle's medium over rabbit blood agar (23 Parasite burden. The numbers of living L. major in infected tissues were determined by using the parasite limiting dilution assay described by Titus et al. (48) . Briefly, different dilutions of infected tissue homogenates were distributed in wells of microtiter plates containing blood agar slants. After 10 to 14 days of incubation at 26°C, the wells containing growing promastigotes were identified by microscopic examination. The frequency ofL. major recovered from footpads, where the cutaneous lesions occurred, was determined by minimum x2 analysis applied to Poisson distribution.
RESULTS
Reinfection of L. major-immune mice triggers an enhanced IFN-y response by spleen and lymph node cells. The control and subsequent cure of the primary infection in either genetically resistant mice or in genetically susceptible mice rendered resistant by treatment with anti-CD4 MAb (here termed experimentally resistant mice) are mediated by the triggering of IFN--y-producing T cells (20, 30, 39 IFN--y production is more rapid in the secondary response than it is in the course of the primary infection (data not shown). Taken together, these results show that reinfection of immune mice induces the expression of a memory response manifested by the enhanced production of the macrophage-activating cytokine IFN--y.
Specificity of the IFN-y production in vitro. IFN-y production by spleen cells in vitro was totally dependent upon the addition of specific antigen in culture (Fig. 3) , i.e., live L. major promastigotes, while lymph node cells, although clearly stimulated by antigen, could produce some IFN--y without addition of exogenous antigen (Fig. 3) . The apparently spontaneous release of IFN--y by lymph node cells was increased by the addition of rmIL-2. The elevated background IFN--y release by lymph nodes cells, draining the site of infection, was clearly due to Leishmania antigens and a few live parasites in these organs (not shown). Exogenous rmIL-2 (30 U/ml) did not increase the IFN--y production by spleen or lymph node cells in the presence of specific antigen. The amount of IFN-y produced was proportional to the number of cells in culture (Fig. 3) . Under the culture conditions used, more than 1.5 x 106 cells per ml were required for clear IFN--y production.
Leishmania-specific CD8+ T cells able to produce IFN'y are present in lymphoid organs of immune mice. Indirect evidence showed that CD8+ T cells contribute to the production of macrophage-activating lymphokines with demonstrable antileishmanial activity (30) . Direct evidence that CD8+ T cells able to produce IFN--y in response to L. major are present in lymphoid tissues of immune mice was obtained by using CD8+ T cells positively sorted by FACS. CD8+ T cells (6 x figure legends) . In addition, the parasite load of immune mice was determined before reinfection (Table 1) , since lesion size alone is an insufficient criterion for the successful resolution of infection (13) . The difference in IFN--y production between immune and immune reinfected mice was less pronounced when the parasite load of the former was high (data not shown).
Similar results were obtained with CD8+ T cells from immune and immune reinfected CBA mice (Fig. 5) experiments because, compared with unfractionated cells, the eluted T cells released significantly less IFN--y upon stimulation with antigen and syngeneic APC from naive mice (Fig. 6) , suggesting that activated responding T cells adhered to nylon wool. This reduced responsiveness could not be attributed to the use of APC from normal mice, since APC from either infected or normal mice are comparable in their elicited by secondary infectious challenge could be demonstrated in both genetically resistant immune CBA mice and experimentally resistant immune BALB/c mice.
The IFN--y produced by lymphoid populations enriched in CD8+ T cells by treatment in vitro with anti-CD4 MAb and complement can be considered to result from CD8+ T cells for several reasons. First, direct proof of the ability of specific CD8+ T cells to produce IFN--y in vitro in response to stimulation with L. major was obtained by using fluorescence-activated-cell-sorted CD8+ T cells. Second, the IFN--y production by populations enriched in CD8+ T cells cannot be due to contaminating CD4+ T cells (<1%) since titration experiments, using unseparated lymphoid cells, revealed that no IFN-y could be detected at low cell densities (<3 x 105 cells per ml). Third, the addition of anti-major histocompatibility complex class I MAbs inhibited the IFN-y response by CD8+ T cells from both strains by 50 to 80% (data not shown). Fourth, the IFN--y response of cultures enriched in CD8+ T cells was both antigen and IL-2 dependent (Fig. 4) , while that of the unseparated cells was only antigen dependent (Fig. 3) . The IL-2 requirement for IFN--y production by CD8+ T cells in response to specific stimulation has been demonstrated in several antigenic systems (7, 17, 19) . The strict antigen dependence of the response observed in the present study makes it unlikely that NK cells are involved to a significant degree, since although NK cells are triggered in Leishmania infection, their specificity for Leishmania antigens has not been shown. y/6 T cells from L. major-infected mice did not release detectable amounts of IFN-y under these conditions and therefore cannot account for the response (37a).
In all experiments described here, CD8+ T cells obtained from immune mice 5 days after reinfection released substantially more IFN--y upon specific stimulation in vitro than those from immune unchallenged mice. The difference could be due either to an increase in the amount of IFN-y released by individual memory cells or to an increase in the frequency of responding memory cells after challenge in vivo. More recent results indicate that reinfection of immune mice leads to increased frequencies of responding CD8+ T cells (manuscript in preparation). CD8+ T cells have been shown to contribute to protective immune responses in Leishmania infection. Susceptible BALB/c mice, when thymectomized, lethally irradiated, and reconstituted with bone marrow cells, or when given anti-CD4 MAb, were able to control a primary infection with L.
major (11, 12 (45) . Upon rechallenge with infectious parasites, the number of CD8+ T cells increased at the time when parasites were eliminated by the immune host (25) . In mice expressing transgenic I-E molecules, a reduced ability to resist infection with L. donovani has been correlated with a reduced capacity to trigger IFN--y-producing CD8+ T cells (18) .
The activation of parasitized macrophages by IFN-,y in combination with other signals leads to destruction of intracellular L. major (2, 9, 15, 32, 34) . The demonstration of an enhanced IFN--y production by memory CD8+ T cells in immune mice upon secondary infectious challenge could account for the role of these cells in conferring resistance to leishmaniasis (6, 28, 29, 30) . Indeed, neutralization of endogenous IFN-y at the time of reinfection of immune mice with L. major results in a clear reduction of the DTH response (Fig. 7) and interferes with the resolution of secondary lesions (manuscript in preparation). A Plasmodium bergheispecific cytolytic CD8+ T-cell clone, which is able to lyse specific peptide-sensitized target cells, was shown to be able to elicit leishmanicidal activity in both syngeneic and allogeneic Leishmania mexicana-infected macrophages, provided that P. berghei peptide-sensitized macrophages were also present in the culture. This leishmanicidal activity was the result of an IFN--y-dependent bystander effect and was not due to the lysis of the infected macrophages (43 their host-protective role by activating infected macrophages to kill the obligate intracellular parasite.
The expansion of Leishmania-specific CD8+ T cells implies that some parasite-derived peptides are able to gain access to the class I major histocompatibility complex pathway of antigen presentation, in spite of the phagolysosomal location of the amastigotes. Alternatively, the destruction of parasites by activated macrophages could lead to the release of parasite-derived antigenic peptides which could bind to major histocompatibility complex class I molecules expressed at the surface of noninfected or parasitized cells, where they could be recognized by CD8+ precursor cells. The latter mechanism is more consistent with the kinetics of appearance of the CD8+ T-cell-mediated antileishmanial effector function, which is more pronounced in the secondary responses in vivo. Accordingly, the destruction of parasites during the resolution of primary infections might be necessary to generate a sufficient amount of Leishmaniaderived peptides to sensitize parasite-specific CD8+ T cells. Since this process would require time, it could explain why CD8+ T cells appear to be more important for the host defense after reinfection. In addition, the well-characterized activation of Leishmania-specific CD4+ T cells at early stages of the infection could be required to provide a helper function necessary for the differentiation and maturation of CD8+ effector cells. Although the experiments reported here were designed to assess the participation of specific CD8+ T cells in response to secondary infection with L. major, it is clear that reinfection also leads to secondary responses of CD4+ T cells. Indeed, results of several experiments have shown that CD4+ T cells produce more IFN--y than CD8+ T cells 5 days after challenge of immune mice. However, recent data indicate that after reinfection, the expansion of specific CD8+ T cells is greater than that of CD4+ T cells (manuscript in preparation). Taken together, these results demonstrate the triggering of secondary CD8+ T-cell responses after infectious challenge of immune mice. These findings do not, of course, preclude an important role for Leishmania-specific CD4+ T cells in immunity to reinfection.
The effector functions of Leishmania-specific CD8+ T cells might be synergized by the activity of CD4+ T cells. Although either T-cell subset alone can contribute to the host defense upon reinfection with L. major, the presence of both subpopulations is required for rapid and successful elimination of the parasites. Indeed, the depletion of both CD4+ and CD8+ T cells in immune resistant CBA mice completely abrogated their resistance to reinfection (28) . Similarly, in mice infected with another intracellular protozoan parasite, Toxoplasma gondii, both CD4+ and CD8+ can be induced to release IFN--y in vitro. The IFN--y releasing CD8+ T cells, however, are the major effectors of immunity in vivo (8) . The control of reactivation of chronic toxoplasmosis depends on the presence of both T-cell subsets as well as IFN-,y synthesis, which again appears to result from a synergy between CD4+ and CD8+ lymphocyte functions (7) .
In conclusion, we provide direct evidence for the elicitation of secondary CD8+ T-cell responses in immune mice after reinfection with L. major. Inasmuch as the memory CD8+T cells were able to secrete IFN--y, a key lymphokine activating macrophages to kill intracellular parasites, the results presented in this report offer a rationale for our previous observations demonstrating a role for CD8+T cells in the control of secondary infection with L. major. As yet, there exists no effective vaccine against leishmaniasis, nor is it known how the specific immune response should be targeted by a vaccine. To this end, the factors directing the immune response to host protection or disease progression have been the subject of many investigations. Our results indicate that CD8+ T cells, in addition to the CD4+ T-cell subsets, should be considered in the development of a vaccine against leishmaniasis.
